TY - JOUR
T1 - Rates and implications for hospitalization of patients <65 years of age with atrial fibrillation/flutter
AU - Naccarelli, Gerald V.
AU - Johnston, Stephen S.
AU - Dalal, Mehul
AU - Lin, Jay
AU - Patel, Parag P.
N1 - Funding Information:
Financial support for the development of this report was provided by Sanofi-Aventis U.S., Bridgewater, New Jersey. Editorial support was provided by Jon Edwards, PhD, and was funded by Sanofi-Aventis U.S. Dr. Naccarelli receives research support from GlaxoSmithKline, London, United Kingdom; Boston Scientific Corporation, Natick, Massachusetts; and Boehringer-Ingelheim, Ingelheim, Germany. Dr. Naccarelli is a consultant for Daiichi-Sankyo, Tokyo, Japan; Biosense Webster, Diamond Bar, California; Ortho-McNeil-Janssen, Titusville, New Jersey; Otsuka Pharmaceutical, Tokyo, Japan; St. Jude Medical, St. Paul, Minnesota; Blue Ash Pharmaceutical, Blue Ash, Ohio; Bristol-Myers Squibb, New York, New York; Sanofi-Aventis, Paris, France; Merck, Whitehouse Station, New Jersey; Portola Pharmaceuticals, South San Francisco, California; GlaxoSmithKline; Boehringer-Ingelheim; Pfizer, New York, New York; Medtronic; Gilead Pharmaceuticals, San Dimas, California; Novartis AG, Basel, Switzerland; and Xention, Cambridge, United Kingdom. Mr. Johnston is an employee in the Healthcare Division of Thomson Reuters, which has a research consulting agreement with Sanofi-Aventis. Dr. Dalal is an employee of Sanofi-Aventis U.S. Dr. Lin was an employee of Sanofi-Aventis U.S. when this study was conducted and is currently an employee of Novosys Health, which has a research consulting agreement with Sanofi-Aventis U.S.
PY - 2012/2/15
Y1 - 2012/2/15
N2 - The responsibility of managing atrial fibrillation (AF) and atrial flutter (AFL) falls predominantly on the Medicare system. Patients with AF or AFL often have a range of cardiovascular (CV) co-morbidities and are frequently hospitalized for AF and other CV causes. The present retrospective cohort study used medical claims data to evaluate the rates of hospitalization and inpatient mortality in elderly (aged <65 years) patients with AF or AFL with Medicare supplemental insurance. The data were extracted from the United States Thomson Reuters MarketScan Medicare Supplemental and Coordination of Benefits Database (January 2004 to December 2007). Patients aged <65 years with <1 inpatient or <2 outpatient nondiagnostic claims for AF or AFL and <12 months of continuous enrollment before their index AF or AFL diagnoses were identified. The frequencies of hospitalization and inpatient death were evaluated over the postindex study period (mean 24.3 months). Of an eligible study population of 55,774 patients with AF or AFL (mean age 77.9 years, 52.2% men), 28,939 patients (51.9%) were hospitalized (all causes) with nonfatal outcomes, 12,652 (22.7%) were rehospitalized, and 1,592 (2.9%) died in the hospital. Higher proportions of patients were hospitalized for non-CV than for CV causes (35.6% vs 27.2%). For CV hospitalizations culminating in inpatient death (n = 516), the most common admission diagnoses were major bleeding, stroke or transient ischemic attack, and congestive heart failure. In conclusion, elderly patients with AF or AFL undergo frequent hospitalization for CV and non-CV causes. Measures that lower inpatient admission rates, particularly readmission rates, may reduce the increasing cost of treating patients with AF or AFL with Medicare supplemental insurance.
AB - The responsibility of managing atrial fibrillation (AF) and atrial flutter (AFL) falls predominantly on the Medicare system. Patients with AF or AFL often have a range of cardiovascular (CV) co-morbidities and are frequently hospitalized for AF and other CV causes. The present retrospective cohort study used medical claims data to evaluate the rates of hospitalization and inpatient mortality in elderly (aged <65 years) patients with AF or AFL with Medicare supplemental insurance. The data were extracted from the United States Thomson Reuters MarketScan Medicare Supplemental and Coordination of Benefits Database (January 2004 to December 2007). Patients aged <65 years with <1 inpatient or <2 outpatient nondiagnostic claims for AF or AFL and <12 months of continuous enrollment before their index AF or AFL diagnoses were identified. The frequencies of hospitalization and inpatient death were evaluated over the postindex study period (mean 24.3 months). Of an eligible study population of 55,774 patients with AF or AFL (mean age 77.9 years, 52.2% men), 28,939 patients (51.9%) were hospitalized (all causes) with nonfatal outcomes, 12,652 (22.7%) were rehospitalized, and 1,592 (2.9%) died in the hospital. Higher proportions of patients were hospitalized for non-CV than for CV causes (35.6% vs 27.2%). For CV hospitalizations culminating in inpatient death (n = 516), the most common admission diagnoses were major bleeding, stroke or transient ischemic attack, and congestive heart failure. In conclusion, elderly patients with AF or AFL undergo frequent hospitalization for CV and non-CV causes. Measures that lower inpatient admission rates, particularly readmission rates, may reduce the increasing cost of treating patients with AF or AFL with Medicare supplemental insurance.
UR - http://www.scopus.com/inward/record.url?scp=84856477979&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856477979&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2011.10.009
DO - 10.1016/j.amjcard.2011.10.009
M3 - Article
C2 - 22118826
AN - SCOPUS:84856477979
SN - 0002-9149
VL - 109
SP - 543
EP - 549
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 4
ER -